<DOC>
	<DOCNO>NCT03018886</DOCNO>
	<brief_summary>The purpose study validate growth hormone release hormone ( GHRH ) plus arginine ( GHRH+arg ) stimulation test itÂ´s cut-off limit diagnosis adult growth hormone deficiency use growth hormone ( GH ) Immulite 2000 Xpi assay calibrate IS 98/574 World Health Organization . A specific aim study effect gender age peak GH response GHRH+arg test</brief_summary>
	<brief_title>Diagnosing Adult Growth Hormone Deficiency</brief_title>
	<detailed_description>Adult growth hormone deficiency ( AGHD ) clinical entity include increase abdominal fat mass , decreased muscle mass , low bone density adverse effect quality life cardiovascular morbidity . These sign nonspecific , accurate diagnosis laboratory test need . The GHRH+arg test use diagnose AGHD , cut-off value vary base control use . At moment consensus cut-off criterion BMI specific , gender age may also affect GH response GHRH+arg .</detailed_description>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Growth Hormone-Releasing Hormone</mesh_term>
	<criteria>health patient : 1. age 2060 year , 2. symptom indicative disease . patient : 1. age 1690 year 2. previous pituitary disease 3. suspicion growth hormone deficiency healthy control : 1. pregnancy , 2. know suspected disease , 3. symptom indicate disease 4. use medication</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>